New appointment at Wyeth
This article was originally published in Scrip
Wyeth (US) has appointed Daniel McIntyrevice-president of corporate communications. He will be responsible for internal and external communications for the company and its three major divisions – pharmaceuticals, consumer healthcare and animal health. He was previously managing director of the healthcare practice of Fleishman-Hillard International Communications. Mr McIntyre also held senior level communications and public policy positions at Pharmacia, Bayer, Bristol-Myers Squibb and Roche.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.